Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | jumonji domain containing protein | 0.0071 | 0.064 | 0.064 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0023 | 0.0046 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0707 | 0.0707 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0001 | 0.0002 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0071 | 0.064 | 0.064 |
Toxoplasma gondii | exonuclease III APE | 0.0023 | 0.0046 | 1 |
Brugia malayi | hypothetical protein | 0.0148 | 0.1584 | 0.2249 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0273 | 0.0387 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0001 | 0.0001 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.3274 | 0.4648 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.1584 | 0.2249 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0001 | 0.0001 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0001 | 0.0001 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0507 | 0.0719 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.0707 | 0.1003 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.064 | 0.064 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0023 | 0.0046 | 0.5 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0023 | 0.0046 | 0.0066 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0071 | 0.064 | 0.064 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0273 | 0.0387 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.3274 | 0.3274 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0023 | 0.0046 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.0707 | 0.1003 |
Brugia malayi | RNA binding protein | 0.0076 | 0.0707 | 0.1003 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0023 | 0.0046 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0507 | 0.0719 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0707 | 0.0707 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.064 | 0.0908 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0023 | 0.0046 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0707 | 0.0707 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0023 | 0.0046 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0593 | 0.7044 | 0.7044 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0707 | 0.0707 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0023 | 0.0046 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.1584 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.228 | 0.228 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0023 | 0.0046 | 0.0066 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0023 | 0.0046 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0001 | 0.0001 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.0707 | 0.0707 |
Echinococcus multilocularis | indoleamine 2,3 dioxygenase 2 | 0.0593 | 0.7044 | 0.7044 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.228 | 0.228 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0001 | 0.0001 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0001 | 0.0001 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0001 | 0.0001 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0071 | 0.064 | 0.064 |
Schistosoma mansoni | hypothetical protein | 0.0593 | 0.7044 | 0.7044 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0023 | 0.0046 | 0.5 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0001 | 0.0001 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0707 | 0.0707 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0071 | 0.064 | 0.0908 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.1584 | 0.2249 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.1584 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0273 | 0.0273 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0483 | 0.0483 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0023 | 0.0046 | 0.0046 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.0707 | 0.1003 |
Echinococcus granulosus | geminin | 0.0205 | 0.228 | 0.228 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0071 | 0.064 | 0.064 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.1538 | 0.2183 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0023 | 0.0046 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.1538 | 0.2183 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.064 | 0.0908 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0001 | 0.0001 |
Brugia malayi | indoleamine 2,3-dioxygenase | 0.0593 | 0.7044 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0001 | 0.0002 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.0707 | 0.1003 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0001 | 0.0002 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0483 | 0.0685 |
Echinococcus multilocularis | geminin | 0.0205 | 0.228 | 0.228 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0001 | 0.0002 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0023 | 0.0046 | 0.5 |
Brugia malayi | hypothetical protein | 0.0286 | 0.3274 | 0.4648 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0483 | 0.0483 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.0707 | 0.0707 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.3274 | 0.3274 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0.0046 | 0.5 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0023 | 0.0046 | 0.0046 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0507 | 0.0719 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0023 | 0.0046 | 0.5 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0023 | 0.0046 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0023 | 0.0046 | 0.0046 |
Loa Loa (eye worm) | indoleamine 2,3-dioxygenase | 0.0593 | 0.7044 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0023 | 0.0046 | 0.0046 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.0707 | 0.1003 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.1538 | 0.2183 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Echinococcus granulosus | indoleamine 23 dioxygenase 2 | 0.0593 | 0.7044 | 0.7044 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0001 | 0.0001 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0507 | 0.0719 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.064 | 0.064 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 40 uM | PUBCHEM_BIOASSAY: HTS Dose response counterscreen for assays utilizing the enzyme, beta-galactosidase - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1966, AID2569] | ChEMBL. | No reference |
IC50 (functional) | = 34.59 um | PUBCHEM_BIOASSAY: Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor. (Class of assay: confirmatory) [Related pubchem assays: 2569, 2521 ] | ChEMBL. | No reference |
Potency (functional) | 0.0794 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.122 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.2944 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 3.6964 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 11.5821 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 33.8078 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.